Bioequivalence of Telmisartan 80 mg Film-coated vs Conventional Tablets

Phase 1, randomised, open-label trial of telmisartan in hypertension (HTN) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve of the analyte in plasma over the time interval from 0 to last quantifiable data point up to 72 hours and Maximum measured concentration of the analyte in plasma up to 72 hours. Started Sep 2008; status: completed.